BREAKTHROUGHS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPLICATIONS

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sector of biopharmaceuticals, providing promising developments across several clinical and industrial applications. With its structural similarity to naturally derived human serum albumin, OsrHSA offers a safer, far more responsible option for therapeutic use, s